1. Home
  2. AVBP vs WEAV Comparison

AVBP vs WEAV Comparison

Compare AVBP & WEAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVBP
  • WEAV
  • Stock Information
  • Founded
  • AVBP 2021
  • WEAV 2011
  • Country
  • AVBP United States
  • WEAV United States
  • Employees
  • AVBP N/A
  • WEAV N/A
  • Industry
  • AVBP
  • WEAV EDP Services
  • Sector
  • AVBP
  • WEAV Technology
  • Exchange
  • AVBP NYSE
  • WEAV Nasdaq
  • Market Cap
  • AVBP 980.3M
  • WEAV 1.1B
  • IPO Year
  • AVBP 2024
  • WEAV 2021
  • Fundamental
  • Price
  • AVBP $27.81
  • WEAV $16.72
  • Analyst Decision
  • AVBP Strong Buy
  • WEAV Strong Buy
  • Analyst Count
  • AVBP 5
  • WEAV 5
  • Target Price
  • AVBP $37.40
  • WEAV $16.50
  • AVG Volume (30 Days)
  • AVBP 140.3K
  • WEAV 726.4K
  • Earning Date
  • AVBP 02-10-2025
  • WEAV 02-19-2025
  • Dividend Yield
  • AVBP N/A
  • WEAV N/A
  • EPS Growth
  • AVBP N/A
  • WEAV N/A
  • EPS
  • AVBP N/A
  • WEAV N/A
  • Revenue
  • AVBP N/A
  • WEAV $195,837,000.00
  • Revenue This Year
  • AVBP N/A
  • WEAV $21.45
  • Revenue Next Year
  • AVBP N/A
  • WEAV $16.13
  • P/E Ratio
  • AVBP N/A
  • WEAV N/A
  • Revenue Growth
  • AVBP N/A
  • WEAV 20.54
  • 52 Week Low
  • AVBP $14.35
  • WEAV $8.10
  • 52 Week High
  • AVBP $36.37
  • WEAV $16.86
  • Technical
  • Relative Strength Index (RSI)
  • AVBP 53.46
  • WEAV 61.27
  • Support Level
  • AVBP $25.90
  • WEAV $15.37
  • Resistance Level
  • AVBP $29.71
  • WEAV $16.86
  • Average True Range (ATR)
  • AVBP 1.49
  • WEAV 0.50
  • MACD
  • AVBP 0.25
  • WEAV 0.01
  • Stochastic Oscillator
  • AVBP 67.85
  • WEAV 67.76

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize team's deep drug development experience to maximize the potential of lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

About WEAV Weave Communications Inc.

Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, it enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue primarily from subscription services.

Share on Social Networks: